Biota Pharmaceuticals IncAdd to My Watchlist

BOTA:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 2.44
  • 0.04  1.67%
    Today's Change
  • 2.40
    Previous Close
  • Today
    52 Week Low - High
1:34 pm ET 10/20/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding35 million
Market Cap$86 million
Return on Equity ttm-14.20%
Last Dividend$6.65
Dividend Yield ttm--
Relative Dividend Yield benchmark--
Dividend Ex-Date11/9/12
Dividend Pay Date11/8/12
EPS: Year Actual ttm-0.309
EPS: Year Est. 6/15 ttm-0.210
EPS: Quarterly Actual 6/14 -0.24
EPS: Quarterly Est. 9/14 -0.12
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-9.38
Company Description
Biota Pharmaceuticals Inc is an anti-infective drug development company with expertise in respiratory diseases, particularly influenza. The Company developed the first neuraminidase inhibitor. Biota's research breakthroughs include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections.
Revenue$69 million
Net Income$-11 million
Total Assets$114 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!